Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Do Not Crush List
    • First-Time Generics
    • Insulin Safety
    • New Drugs
    • Original Container Meds
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (716)
    • Blood Glucose Meters (12)
    • Complications (120)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (79)
    • Drug-Induced Hypo/Hyperglycemia (103)
    • Monitoring (99)
    • Natural Medicines/Supplements (12)
    • Prevention (32)
    • Treatment (282)
      • Alpha-Glucosidase Inhibitors (19)
      • Amylin Agonist (16)
      • Bromocriptine (5)
      • Combination Products (20)
      • Gliptins (66)
      • Glitazones (95)
      • GLP-1 (29)
      • Incretin Enhancers/Mimetics (59)
      • Insulin (165)
      • Meglitinides (37)
      • Metformin (102)
      • SGLT2 Inhibitors (52)
      • Sulfonylureas (98)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (7)
  • Hyperglycemia (34)
  • Hypoglycemia (16)
  • Other (20)
  • Prediabetes (2)
  • Resources (165)
  • Thyroid Disorders (60)
1 - 15 of 282 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Watch for Bexagliflozin, a New Med for Type 2 Diabetes September 2023
FAQ: Management of Severe Hypertension in Adults September 2023
Chart: Drugs for Type 2 Diabetes
August 2023
FAQ: Canadian Dyslipidemia Recommendations July 2023
Chart: Potentially Harmful Drugs: Beers Criteria
July 2023
Article: Prevent Mishaps When Patients Start Insulin for Type 2 Diabetes May 2023
FAQ: Continuous Glucose Monitoring
May 2023
Chart: How to Switch Insulin Products May 2023
Article: Stay on Top of Changes With Insulin Products April 2023
Article: Don’t Expect to Always See Metformin First for Type 2 Diabetes February 2023
Toolbox: Improving Diabetes Outcomes February 2023
Chart: Managing Polycystic Ovary Syndrome February 2023
Chart: Drugs With Prescribing, Dispensing, or REMS Requirements February 2023
Chart: Treatment of Hypertension January 2023
Article: Stay Alert for Meds That Can Exacerbate Heart Failure November 2022
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved